Antacid Regular Strength
NDC Package 70692-118-45

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings
Table of Contents
    1. Package Information
    2. Frequently Asked Questions

Package Information

This product is EXCLUDED from the official NDC directory because the listing data was inactivated by the FDA.

Antacid Regular Strength is relieves:acid indigestionheartburn. Marketed by Strive Pharmaceuticals Inc., this product is identified by NDC 70692-118 and is authorized under FDA application part331.

Identification & Billing

NDC Package Code
70692-118-45
Package Description
45 TABLET, CHEWABLE in 1 PACKAGE
Product Code
70692-118
11-Digit Billing Format
70692011845
RxNorm Crosswalk
  • RxCUI: 308907 - calcium carbonate 500 MG (Ca 200 MG) Chewable Tablet
  • RxCUI: 308907 - calcium carbonate 500 MG Chewable Tablet
  • RxCUI: 308907 - calcium carbonate 500 MG (equivalent to calcium 200 MG) Chewable Tablet

Clinical Specifications

Proprietary Name
Antacid Regular Strength
Dosage Form
-
Usage Information
Relieves:acid indigestionheartburn

Regulatory & Marketing

Labeler Name
Strive Pharmaceuticals Inc.
FDA Application #
part331
Marketing Category
OTC MONOGRAPH FINAL - A product marketed pursuant to a final Over-the-Counter (OTC) Drug Monograph.
Start Marketing Date
05-09-2018
Listing Expiration
12-31-2021
Exclude Flag
I
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 70692-118-45 identifies a specific commercial package of 45 tablet, chewable in 1 package of Antacid Regular Strength, labeled by Strive Pharmaceuticals Inc.. This is formulated for use and contains as the active substance.

Is this product currently listed with the FDA?

This product code is currently listed as inactive or excluded from the primary directory. It was introduced to the market by Strive Pharmaceuticals Inc. on May 09, 2018. The current certification is valid through December 31, 2021.

How is this Strive Pharmaceuticals Inc. product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 70692011845. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-3-2)
70692-118-45
11-Digit CMS (5-4-2)
70692-0118-45

Note: The zero is added to the Product segment to maintain the 5-4-2 structure.